Cardinal Health, Inc. (NYSE:CAH) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Cardinal Health, Inc. (NYSE:CAH) have been assigned an average recommendation of “Moderate Buy” from the eighteen brokerages that are covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and fifteen have given a buy recommendation to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $251.7333.

A number of brokerages recently issued reports on CAH. Robert W. Baird set a $248.00 price objective on shares of Cardinal Health in a report on Friday, May 1st. Wells Fargo & Company reduced their target price on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Evercore decreased their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research report on Wednesday, April 8th. Weiss Ratings downgraded shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. Finally, TD Cowen lifted their price target on shares of Cardinal Health from $255.00 to $275.00 and gave the stock a “buy” rating in a report on Thursday, July 9th.

Cardinal Health Stock Up 0.9%

Shares of CAH stock opened at $227.96 on Friday. Cardinal Health has a twelve month low of $137.75 and a twelve month high of $243.21. The stock’s fifty day simple moving average is $219.98 and its 200 day simple moving average is $214.43. The firm has a market capitalization of $53.39 billion, a P/E ratio of 34.86, a P/E/G ratio of 1.12 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. During the same period last year, the company earned $2.35 earnings per share. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities research analysts expect that Cardinal Health will post 10.77 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were given a dividend of $0.5158 per share. The ex-dividend date of this dividend was Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is 31.50%.

Institutional Investors Weigh In On Cardinal Health

A number of institutional investors have recently made changes to their positions in CAH. Norges Bank acquired a new stake in shares of Cardinal Health in the fourth quarter valued at about $790,344,000. Wellington Management Group LLP raised its position in shares of Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after acquiring an additional 3,511,579 shares during the last quarter. Marshall Wace LLP lifted its stake in shares of Cardinal Health by 1,328.1% in the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock worth $195,484,000 after acquiring an additional 884,648 shares during the period. Bessemer Group Inc. lifted its stake in shares of Cardinal Health by 7,053.4% in the first quarter. Bessemer Group Inc. now owns 750,038 shares of the company’s stock worth $158,491,000 after acquiring an additional 739,553 shares during the period. Finally, Vanguard Group Inc. boosted its holdings in Cardinal Health by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock valued at $6,461,179,000 after acquiring an additional 617,775 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.